Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Respiration ; 69(5): 456-60, 2002.
Article in English | MEDLINE | ID: mdl-12232456

ABSTRACT

Among embryonic aortic vascular malformations, persistence of a right aortic arch and aberrant left subclavian artery associated with a diverticulum of Kommerell is rare, and is estimated to occur in 0.1% of the general population. We report two cases of diverticulum of Kommerell in which tracheal compression due to the vascular ring induced respiratory symptoms such as asthmatic dyspnoea. This reminds us that at least a chest X-ray should be performed in newly diagnosed asthmatic patients, focusing on the trachea and upper mediastinum. In case of vascular abnormality, angiography and magnetic resonance are the best investigations to define the abnormal anatomy and guide surgery.


Subject(s)
Aorta, Thoracic/abnormalities , Asthma/diagnosis , Diverticulum/diagnosis , Adult , Aorta, Thoracic/surgery , Diagnosis, Differential , Diverticulum/congenital , Diverticulum/surgery , Female , Humans , Subclavian Artery/abnormalities , Subclavian Artery/transplantation , Tracheal Stenosis/etiology
2.
Intensive Care Med ; 28(6): 686-91, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12107671

ABSTRACT

OBJECTIVE: To compare the outcome of patients with severe Legionella pneumonia (LP) according to the presence or absence of prognostic factors currently reported in the literature and delays in initiating fluoroquinolones and macrolides. DESIGN: Retrospective clinical investigation. SETTING: Intensive care unit (ICU) of an university hospital. PATIENTS: Forty-three consecutive cases with no previous treatment with a macrolide or a fluoroquinolone. MEASUREMENTS AND MAIN RESULTS: The 14 (33%) patients who died of LP were compared with the 29 survivors. Thirty-eight patients (88%) received a fluoroquinolone in combination with a macrolide agent, two patients erythromycin alone and three ofloxacin alone. In univariate analysis, SAPS II more than 46 ( p=0.006) and intubation requirement ( p=0.012) were associated with a higher mortality whereas the administration of fluoroquinolones ( p=0.011) or erythromycin ( p=0.044) within 8 h of arrival on the ICU was associated with better survival. By logistic regression analysis, SAPS II score more than 46 [odds ratio (OR) 8.69; 95% confidence interval (CI) 1.15-66.7; p=0.036], duration of symptoms prior to ICU admission longer than 5 days (OR 7.46; 95% CI 1.17-47.6) were independent risk factors for death. Fluoroquinolone administration within 8 h of ICU arrival (OR 0.16; 95% CI 0.03-0.96; p=0.035) was associated with a reduced mortality. CONCLUSIONS: SAPS II score higher than 46, duration of symptoms prior to ICU admission longer than 5 days and intubation were associated with increased mortality. Initiation of fluoroquinolone therapy within 8 h of ICU admission significantly reduced mortality.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/therapeutic use , Legionella pneumophila , Legionnaires' Disease/drug therapy , APACHE , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/administration & dosage , Anti-Infective Agents/administration & dosage , Drug Therapy, Combination , Female , Fluoroquinolones , Humans , Intensive Care Units , Legionnaires' Disease/classification , Legionnaires' Disease/mortality , Macrolides , Male , Middle Aged , Prognosis , Retrospective Studies , Time Factors
3.
Rev Pneumol Clin ; 58(1): 19-22, 2002 Feb.
Article in French | MEDLINE | ID: mdl-11981500

ABSTRACT

Tracheobronchomegaly is defined as a dilatation of the trachea and the large bronchi. It may occur as a familial condition or in association with a connective tissue disease, e.g. Ehlers-Danlos syndrome. Tracheobronchomegaly occurs late in adults. The predominant symptoms are bronchial irritation and recurrent bronchopulmonary infections (because of ineffective cough). Diagnosis is provided by thoracic imaging, particularly computed tomography that enables measuring the precise diameter of the trachea. We report the case of one patient with tracheobronchomegaly who was greatly improved after implantation of Ultraflex tracheobronchial prostheses.


Subject(s)
Prostheses and Implants , Tracheobronchomegaly/therapy , Diagnosis, Differential , Follow-Up Studies , Humans , Male , Middle Aged , Prosthesis Design , Tomography, X-Ray Computed , Tracheobronchomegaly/diagnosis , Tracheobronchomegaly/etiology
4.
Pathol Res Pract ; 197(12): 797-801, 2001.
Article in English | MEDLINE | ID: mdl-11795826

ABSTRACT

Specified galectins are known to play a role in regulating cell proliferation, differentiation, adhesion and migration. Po66, a mouse IgG1 monoclonal antibody produced by immunization against squamous cell cancer, reacts against a carbohydrate-binding protein (Po66-CBP), recently shown to be a member of the galectin family with a strong homology with galectin-8 (PCTA-1), identified as a human tumor-associated antigen. We studied Po66 in squamous metaplasia of the bronchi in order to determine whether it could be specifically involved in neoplastic conditions and if so, if it would be helpful in distinguishing metaplasia at risk of cancer. Twenty-eight formalin-fixed, paraffin-embedded archival tissues of 17 metaplasias with SCC, 3 metaplasia with distant neoplastic disease and 8 metaplasias with an inflammatory process, were immunostained using a streptavidin biotin peroxydase method. The squamous metaplasias were positively stained in non-neoplastic disease as well as in neoplastic processes. Expression was also observed in stromal and normal cells. Po66-CBP was not associated with a pre-neoplastic character. We discussed the expression of this intra-cellular component of galectin-8 according to the functions of galectins in cellular differentiation, host reaction against tumor, and inflammation.


Subject(s)
Bronchi/metabolism , Carcinoma in Situ/metabolism , Carcinoma, Squamous Cell/metabolism , Galectins , Lectins/metabolism , Lung Diseases, Interstitial/metabolism , Lung Neoplasms/metabolism , Biomarkers, Tumor/metabolism , Bronchi/pathology , Carcinoma in Situ/pathology , Carcinoma, Squamous Cell/pathology , Epithelial Cells/metabolism , Epithelial Cells/pathology , Humans , Immunoenzyme Techniques , Lectins/analysis , Lung Diseases, Interstitial/pathology , Lung Neoplasms/pathology , Metaplasia/metabolism , Metaplasia/pathology
5.
Bull Cancer ; 87(10): 703-7, 2000 Oct.
Article in French | MEDLINE | ID: mdl-11084533

ABSTRACT

Galectins are proteins structurally related to the lectin family. They share, with lectins, the ability to bind carbohydrate residues. Galectins are suspected to mediate several biological functions such as embryonic development growth, immune response and apoptosis. Their role is similar to that of adhesion molecules in cell to cell or to matrix interactions. Their contribution to human carcinogenesis has been suggested from experimental studies. In clinical research, they could be used as a differentiation marker, particularly in thyroid carcinomas and in certain lymphomas.


Subject(s)
Hemagglutinins/physiology , Animals , Antigens, Differentiation/drug effects , Antigens, Differentiation/physiology , Biomarkers, Tumor/metabolism , Cell Communication , Cell Physiological Phenomena , Embryonic and Fetal Development , Galectin 3 , Galectins , Hemagglutinins/chemistry , Hemagglutinins/drug effects , Humans , Immunity , Ligands , Neoplasm Metastasis , Neoplasms/therapy , Tumor Cells, Cultured
6.
Anticancer Res ; 19(6B): 5429-33, 1999.
Article in English | MEDLINE | ID: mdl-10697573

ABSTRACT

UNLABELLED: A monoclonal antibody, Po66, recognized an antigen named Po66 carbohydrate binding protein (PO66-CBP), which was homologous to the galectin-8 protein. Two additional isoforms previously not described were characterized. The aim of this study was to compare the expression of Po66-CBP and its isoforms in different healthy, tumoral and peritumoral tissues and at last to determine the localization of the protein in tumors and distant tissues. MATERIALS AND METHODS: Reverse transcriptase PCR of Po66-CBP was performed on total RNA extract from eleven healthy and eleven tumoral and peritumoral tissue specimens. Antibody Po66 was used to localize the protein in the tumors and distant tissues by an immunohistochemistry method. RESULTS: Po66-CBP was expressed by half of the healthy tissues. One of the isoforms, the last often present in healthy tissues, was found in all tumoral and peritumoral tissues studied. Immunohistochemistry evidenced a gradient of protein expression in normal cells depending on the vicinity of tumoral tissue. Po66-CBP expression was modified in cancerous tissue, suggesting the implication of galectins in carcinogenesis.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Galectins , Lectins/metabolism , Lung Neoplasms/metabolism , Base Sequence , DNA Primers , Humans , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...